1. Which of the following monoclonal antibody therapies is available in both intravenous and subcutaneous dosage forms?

2. Which of the following monoclonal antibodies is authorized by the FDA for postexposure prophylaxis?

3. Which of the following patients would be eligible for monoclonal antibody therapy?

4. Which of the following studies was critical in the FDA's authorization for sotrovimab as a treatment for mild-to-moderate COVID-19?

5. Which of the following is a known advantage of monoclonal antibodies when used to treat COVID-19?

Evaluation Questions

6. To what extent did the program meet objective #1?

7. To what extent did the program meet objective #2?

8. Rate the effectiveness of how well the program related to your educational needs:

9. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

10. Rate the quality of the faculty:

11. Rate the effectiveness and the overall usefulness of the material presented:

12. Rate the appropriateness of the examination for this activity:

13. Rate the effectiveness of how well the activity related to your practice needs:

14. Rate the effectiveness of how well the activity will help you improve patient care:

15. Will the information presented cause you to change your practice?

16. Are you committed to making these changes?

17. As a result of this activity, did you learn something new?

18. What is your practice setting or area of practice?

19. How many years have you been in practice?

« Return to Activity